Exchange: NYSE·Updated 07:30 PM EDT
News
all
press releases
Medifast Announces the Launch of the Medifast Metabolic Health Institute
Medifast, Inc. (NYSE: MED) has announced the launch of the Medifast Metabolic Health Institute, established to advance metabolic health through rigorous research and credible, evidence-based education. The institute brings Medifasts clinical research, scientific expertise, and educational resources...
Business Wire
More News
Can Medifast Capitalize on Rising GLP-1 Use With Metabolic Health?
MED's Trilivy launch marks a major metabolic-health shift, backed by a 10-year roadmap and growing GLP-1 market focus.
Zacks
All You Need to Know About Medifast (MED) Rating Upgrade to Buy
Medifast (MED) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks
AB InBev Leverages Premiumization and Digital Platforms for Growth
BUD is premiumizing its portfolio, expanding no-alcohol and Beyond Beer offerings, and scaling digital platforms to drive growth.
Zacks
Can Medifast's New Compensation Plan Accelerate Coach Growth?
MED is reshaping its coach network around Executive Directors as productivity rises despite a sharp decline in active earning coaches.
Zacks
Kenvue Q2 Deep Dive: Assessing Financial Metrics & Growth Prospects
KVUE's Q2 sales and earnings miss estimates, but organic growth improved as Skin Health and Beauty led a broader recovery.
Zacks
Can Medifast's Coach Productivity Gains Help Revive Revenue Growth?
MED's improving coach productivity and client retention point to stabilization, but a shrinking coach base remains a challenge.
Zacks
Dole's Q2 Earnings Miss Estimates on Higher Fresh Fruit Costs
DOLE's Q2 earnings miss estimates as higher fruit sourcing, fuel and shipping costs pressured Fresh Fruit, despite strong Americas growth.
Zacks
Can MED's Trilivy Launch and Cost Cuts Drive a Q4 Profit Turnaround?
Medifast's Trilivy launch and cost cuts could support a Q4 profit turnaround, but shrinking revenue and its coach base keep risks high.
Zacks
MED Rallies 13.6% in the Past Month: Can the Momentum Keep Building?
Medifast stock gains 13.6% in a month as improving coach productivity and earnings expectations support momentum despite weaker revenue.
Zacks

Advertisement|Remove ads.